On February 7, 2023 Derm-Biome Pharmaceuticals, Inc, a Vancouver based biopharmaceutical company focused on skin health, ireported that it has been invited to present at the 2023 OBIO Investment Summit (OIS) in Toronto on Friday, February 10th at 11:51am EST (Press release, Derm-Biome Pharmaceuticals, FEB 7, 2023, View Source;utm_medium=rss&utm_campaign=derm-biome-pharmaceuticals-to-present-at-the-2023-obio-investment-summit-on-february-10-2023 [SID1234626912]). The Summit is Canada’s premier health science investment event, a forum that connects global investors with Canada’s best technology innovators. Since 2018 summit companies have raised $1.3 billion.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Derm-Biome CEO Gordon Eberwein: "The OBIO Investment Summit will be the kick off to a seed round that will fund the advancement of our topical skin disease drug through a phase I clinical trial, a significant milestone for our company. We look forward to presenting our exciting technology and meeting people from the life sciences investment community."